Terminated PHASE2 INTERVENTIONAL 1-arm NCT03150628

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study (CISCA)

Sponsor: Richard van Hillegersberg

Conditions Gastric Cancer HIPEC Peritoneal Carcinomatosis

Interventions Cytoreduction HIPEC Perioperative chemotherapy

Updated 8 times since 2017 Last updated: Apr 16, 2019 Started: Aug 1, 2017 Primary completion: Apr 23, 2018 Completion: Apr 23, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Conflicting recruitment with PERISCOPE II study (NCT03348150)

Other Gastric Cancer trials with similar outcome

Browse all Gastric Cancer trials

A PHASE2 clinical study on Gastric Cancer and HIPEC, this trial is terminated or withdrawn. The trial is conducted by Richard van Hillegersberg and has accumulated 8 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
May 2019 — Jan 2021 [monthly]

Terminated PHASE2

Status: Suspended → Terminated
Jun 2018 — May 2019 [monthly]

Suspended PHASE2

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Suspended PHASE2

Status: Recruiting → Suspended
Nov 2017 — May 2018 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jul 2017 — Nov 2017 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Richard van Hillegersberg

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands